Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
13 Apr 2022

FAP-targeted molecular radiotherapy in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA
FAP-targeted molecular radiotherapy in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )
1 Apr 2022

FAP-targeted PET imaging in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA
FAP-targeted PET imaging in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )
1 Apr 2022

Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC

Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC ( Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
31 Mar 2022

METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours

Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours ( Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
31 Mar 2022

Real-world increase in biomarker testing in lung cancer

Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Real-world increase in biomarker testing in lung cancer ( Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
30 Mar 2022

EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari
EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )
30 Mar 2022

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408

Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )
3 Mar 2022

Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan

Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )
1 Mar 2022

Cancer nursing in India: Febrile neutropenia

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Cancer nursing in India: Febrile neutropenia ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
28 Feb 2022

Cancer nursing in India: Tumour lysis syndrome

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Cancer nursing in India: Tumour lysis syndrome ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
28 Feb 2022

NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion

Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion ( Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA )
28 Feb 2022